{
  "schemaVersion": "1.3.4",
  "title": "Antidepressants - single study B/R analysis (Tervonen et al, Stat Med, 2011)",
  "description": "Application of SMAA to evaluate the potential benefits and risks of two commonly prescribed second-generation antidepressants in the setting of a published placebo-controlled trial (Tervonen et al, Stat Med, 2011)",
  "criteria": {
    "treatmentRespondersId": {
      "title": "Treatment responders",
      "description": "Proportion of patients with a 50% or greater decrease on the HAM-D-21 rating scale",
      "isFavorable": true,
      "dataSources": [
        {
          "pvf": {
            "range": [0.28, 0.63],
            "direction": "increasing",
            "type": "linear"
          },
          "id": "029909c4-cb8c-43cb-9816-e8550ef561be",
          "source": "Nemeroff and Thase (2007)",
          "unitOfMeasurement": "%",
          "scale": [0, 100]
        }
      ]
    },
    "nauseaId": {
      "title": "Nausea ADRs",
      "description": "Proportion of patients experiencing nausea ADRs",
      "isFavorable": false,
      "dataSources": [
        {
          "pvf": {
            "range": [0.04, 0.5],
            "direction": "decreasing",
            "type": "linear"
          },
          "id": "1300eea2-fa03-4f1f-9abb-d4dfb77b99a1",
          "source": "Nemeroff and Thase (2007)",
          "unitOfMeasurement": "Proportion",
          "scale": [0, 1]
        }
      ]
    },
    "insomniaId": {
      "title": "Insomnia ADRs",
      "description": "Proportion of patients experiencing insomnia ADRs",
      "isFavorable": false,
      "dataSources": [
        {
          "pvf": {
            "range": [0.08, 0.31],
            "direction": "decreasing",
            "type": "linear"
          },
          "id": "d0f230ea-284b-4c53-8ae4-0c426fa20c71",
          "source": "Nemeroff and Thase (2007)",
          "unitOfMeasurement": "Proportion",
          "scale": [0, 1]
        }
      ]
    },
    "anxietyId": {
      "title": "Anxiety ADRs",
      "description": "Proportion of patients experiencing anxiety ADRs",
      "isFavorable": false,
      "dataSources": [
        {
          "pvf": {
            "range": [0, 0.17],
            "direction": "decreasing",
            "type": "linear"
          },
          "id": "6eeaa6f5-1407-49f2-b0bf-e1a498dfca4f",
          "source": "Nemeroff and Thase (2007)",
          "unitOfMeasurement": "Proportion",
          "scale": [0, 1]
        }
      ]
    }
  },
  "alternatives": {
    "placeboId": {
      "title": "Placebo"
    },
    "fluoxetineId": {
      "title": "Fluoxetine"
    },
    "venlafaxineId": {
      "title": "Venlafaxine"
    }
  },
  "performanceTable": [
    {
      "alternative": "placeboId",
      "criterion": "treatmentRespondersId",
      "dataSource": "029909c4-cb8c-43cb-9816-e8550ef561be",
      "performance": {
        "effect": {
          "type": "exact",
          "value": 0.36633663366336633,
          "input": {
            "events": 37,
            "sampleSize": 101
          }
        },
        "distribution": {
          "type": "dbeta",
          "parameters": {
            "alpha": 38,
            "beta": 65
          }
        }
      }
    },
    {
      "alternative": "fluoxetineId",
      "criterion": "treatmentRespondersId",
      "dataSource": "029909c4-cb8c-43cb-9816-e8550ef561be",
      "performance": {
        "effect": {
          "type": "exact",
          "value": 0.45,
          "input": {
            "events": 45,
            "sampleSize": 100
          }
        },
        "distribution": {
          "type": "dbeta",
          "parameters": {
            "alpha": 46,
            "beta": 56
          }
        }
      }
    },
    {
      "alternative": "venlafaxineId",
      "criterion": "treatmentRespondersId",
      "dataSource": "029909c4-cb8c-43cb-9816-e8550ef561be",
      "performance": {
        "effect": {
          "type": "exact",
          "value": 0.53125,
          "input": {
            "events": 51,
            "sampleSize": 96
          }
        },
        "distribution": {
          "type": "dbeta",
          "parameters": {
            "alpha": 52,
            "beta": 46
          }
        }
      }
    },
    {
      "alternative": "placeboId",
      "criterion": "nauseaId",
      "dataSource": "1300eea2-fa03-4f1f-9abb-d4dfb77b99a1",
      "performance": {
        "effect": {
          "type": "exact",
          "value": 0.0784313725490196,
          "input": {
            "events": 8,
            "sampleSize": 102
          }
        },
        "distribution": {
          "type": "dbeta",
          "parameters": {
            "alpha": 9,
            "beta": 95
          }
        }
      }
    },
    {
      "alternative": "fluoxetineId",
      "criterion": "nauseaId",
      "dataSource": "1300eea2-fa03-4f1f-9abb-d4dfb77b99a1",
      "performance": {
        "effect": {
          "type": "exact",
          "value": 0.21568627450980393,
          "input": {
            "events": 22,
            "sampleSize": 102
          }
        },
        "distribution": {
          "type": "dbeta",
          "parameters": {
            "alpha": 23,
            "beta": 81
          }
        }
      }
    },
    {
      "alternative": "venlafaxineId",
      "criterion": "nauseaId",
      "dataSource": "1300eea2-fa03-4f1f-9abb-d4dfb77b99a1",
      "performance": {
        "effect": {
          "type": "exact",
          "value": 0.4,
          "input": {
            "events": 40,
            "sampleSize": 100
          }
        },
        "distribution": {
          "type": "dbeta",
          "parameters": {
            "alpha": 41,
            "beta": 61
          }
        }
      }
    },
    {
      "alternative": "placeboId",
      "criterion": "insomniaId",
      "dataSource": "d0f230ea-284b-4c53-8ae4-0c426fa20c71",
      "performance": {
        "effect": {
          "type": "exact",
          "value": 0.13725490196078433,
          "input": {
            "events": 14,
            "sampleSize": 102
          }
        },
        "distribution": {
          "type": "dbeta",
          "parameters": {
            "alpha": 15,
            "beta": 89
          }
        }
      }
    },
    {
      "alternative": "fluoxetineId",
      "criterion": "insomniaId",
      "dataSource": "d0f230ea-284b-4c53-8ae4-0c426fa20c71",
      "performance": {
        "effect": {
          "type": "exact",
          "value": 0.14705882352941177,
          "input": {
            "events": 15,
            "sampleSize": 102
          }
        },
        "distribution": {
          "type": "dbeta",
          "parameters": {
            "alpha": 16,
            "beta": 88
          }
        }
      }
    },
    {
      "alternative": "venlafaxineId",
      "criterion": "insomniaId",
      "dataSource": "d0f230ea-284b-4c53-8ae4-0c426fa20c71",
      "performance": {
        "effect": {
          "type": "exact",
          "value": 0.22,
          "input": {
            "events": 22,
            "sampleSize": 100
          }
        },
        "distribution": {
          "type": "dbeta",
          "parameters": {
            "alpha": 23,
            "beta": 79
          }
        }
      }
    },
    {
      "alternative": "placeboId",
      "criterion": "anxietyId",
      "dataSource": "6eeaa6f5-1407-49f2-b0bf-e1a498dfca4f",
      "performance": {
        "effect": {
          "type": "exact",
          "value": 0.00980392156862745,
          "input": {
            "events": 1,
            "sampleSize": 102
          }
        },
        "distribution": {
          "type": "dbeta",
          "parameters": {
            "alpha": 2,
            "beta": 102
          }
        }
      }
    },
    {
      "alternative": "fluoxetineId",
      "criterion": "anxietyId",
      "dataSource": "6eeaa6f5-1407-49f2-b0bf-e1a498dfca4f",
      "performance": {
        "effect": {
          "type": "exact",
          "value": 0.06862745098039216,
          "input": {
            "events": 7,
            "sampleSize": 102
          }
        },
        "distribution": {
          "type": "dbeta",
          "parameters": {
            "alpha": 8,
            "beta": 96
          }
        }
      }
    },
    {
      "alternative": "venlafaxineId",
      "criterion": "anxietyId",
      "dataSource": "6eeaa6f5-1407-49f2-b0bf-e1a498dfca4f",
      "performance": {
        "effect": {
          "type": "exact",
          "value": 0.1,
          "input": {
            "events": 10,
            "sampleSize": 100
          }
        },
        "distribution": {
          "type": "dbeta",
          "parameters": {
            "alpha": 11,
            "beta": 91
          }
        }
      }
    }
  ]
}
